Treatment for clear cell carcinoma of the abdominal wall at a tertiary cancer center.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
25 06 2022
25 06 2022
Historique:
received:
28
12
2021
accepted:
15
06
2022
entrez:
25
6
2022
pubmed:
26
6
2022
medline:
29
6
2022
Statut:
epublish
Résumé
Clear cell carcinoma (CCC) of the abdominal wall is a rare and agressive disease. We aim to elucidate the clinical and prognostic characteristics of this disease. Medical records of ten patients diagnosed with CCC of the abdominal wall at Fudan University Shanghai Cancer Center were reviewed. We illustrate the clinical characteristics, treatment modality, and development of local recurrence or distant metastasis, as well as the survival outcome. The median (range) age of patients was 47 (39-61) years old. All patients had a history of cesarean section and abdominal wall endometriosis. All patients had primary surgery before referred to our center. Seven patients had only tumor resection, while two patients had lymph node metastasis at primary diagnosis. Four patients underwent supplementary surgery, and all postoperative pathology were negative. Genetic analyses had also been performed. The median (range) follow-up time was 20 (12-59) months. Local recurrence and lymph node metastasis were the most common recurrence types. The median (95% confidence interval) PFS was 11 (8.08-13.92) months. In summary, primary surgery should consider wide tumor resection and lymph node dissection. Adjuvant chemotherapy and radiotherapy should be recommended for potential benefits. More cases are still needed to elucidate the clinical management of this disease.
Identifiants
pubmed: 35752641
doi: 10.1038/s41598-022-14917-0
pii: 10.1038/s41598-022-14917-0
pmc: PMC9233660
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
10820Informations de copyright
© 2022. The Author(s).
Références
Acta Cytol. 2003 Nov-Dec;47(6):1095-8
pubmed: 14674088
In Vivo. 2020 Jul-Aug;34(4):2147-2152
pubmed: 32606196
J Natl Compr Canc Netw. 2020 Sep 24;19(2):172-180
pubmed: 32971514
Fertil Steril. 2008 Oct;90(4):1197.e13-6
pubmed: 18082734
Am J Obstet Gynecol. 2012 Aug;207(2):e7-9
pubmed: 22840730
World J Surg Oncol. 2016 Dec 3;14(1):300
pubmed: 27912770
Am J Obstet Gynecol. 2014 Oct;211(4):363.e1-5
pubmed: 24732005
Geburtshilfe Frauenheilkd. 1986 Sep;46(9):658-9
pubmed: 3770417
World J Surg Oncol. 2014 Mar 05;12:51
pubmed: 24597651
Arch Gynecol Obstet. 2009 Oct;280(4):637-41
pubmed: 19219617
Int J Gynecol Cancer. 2019 Oct;29(8):1332-1335
pubmed: 31451559
Sao Paulo Med J. 2018;136(6):586-590
pubmed: 29116312
J Reprod Med. 2014 May-Jun;59(5-6):330-2
pubmed: 24937978
Case Rep Obstet Gynecol. 2015;2015:123740
pubmed: 26457213
J Cutan Pathol. 2012 Nov;39(11):1035-41
pubmed: 22882475
Gynecol Obstet Invest. 2007;63(3):140-2
pubmed: 17057400
Obstet Gynecol. 2007 Aug;110(2 Pt 2):469-71
pubmed: 17666631
Int J Environ Res Public Health. 2019 Feb 14;16(4):
pubmed: 30769847
Gynecol Oncol. 1998 Jul;70(1):127-30
pubmed: 9698489
Int J Gynecol Cancer. 2015 Nov;25(9):1633-8
pubmed: 26448542